NASDAQ:SILK
Silk Road Medical, Inc
- Stock
Last Close
20.56
08/05 20:00
Market Cap
590.02M
Beta: 1.17
Volume Today
453.68K
Avg: 562.88K
PE Ratio
−10.96
PFCF: −20.84
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 4.50M - | 8.03M 78.67% | 10.16M 26.42% | 13.92M 37.07% | 18.57M 33.42% | 24.58M 32.37% | ||
average payables | 1.40M - | 1.57M 12.58% | 2.25M 42.73% | 2.49M 10.70% | 2.45M 1.51% | 4.10M 67.26% | ||
average receivables | 4.87M - | 6.56M 34.78% | 8.84M 34.68% | 10.45M 18.28% | 14.92M 42.76% | 20.79M 39.35% | ||
book value per share | -4.10 - | -0.46 88.76% | 3.13 779.77% | 3.26 4.13% | 2.29 29.84% | 4.58 100.22% | 3.90 14.96% | |
capex per share | -0.02 - | -0.08 330.36% | -0.02 70.60% | -0.03 9.60% | -0.14 437.84% | -0.14 1.84% | -0.04 72.24% | |
capex to depreciation | -3.43 - | -4.40 28.19% | -0.41 90.61% | -0.61 46.41% | -2.48 309.60% | -1.58 36.28% | -0.40 74.84% | |
capex to operating cash flow | 0.02 - | 0.10 498.00% | 0.02 82.78% | 0.02 10.78% | 0.12 510.55% | 0.15 25.71% | 0.05 69.36% | |
capex to revenue | -0.03 - | -0.07 111.98% | -0.01 87.18% | -0.01 32.54% | -0.05 318.92% | -0.04 23.01% | -0.01 76.43% | |
cash per share | 1.39 - | 0.87 37.20% | 3.95 353.87% | 4.47 13.25% | 3.18 28.86% | 5.97 87.66% | 4.68 21.70% | |
days of inventory on hand | 231.14 - | 192.80 16.59% | 236.55 22.69% | 171.25 27.61% | 256.06 49.53% | 185.92 27.39% | 217.89 17.19% | |
days payables outstanding | 110.02 - | 42.03 61.80% | 43.50 3.50% | 44.54 2.40% | 34.12 23.38% | 24.31 28.75% | 41.40 70.26% | |
days sales outstanding | 133.50 - | 47.74 64.24% | 49.55 3.79% | 44.01 11.19% | 42.56 3.29% | 47.41 11.39% | 48.57 2.46% | |
debt to assets | 0.64 - | 1.08 68.85% | 0.33 69.79% | 0.28 15.68% | 0.31 12.88% | 0.28 8.82% | 0.29 2.83% | |
debt to equity | -0.28 - | -3.34 1,094.03% | 0.62 118.68% | 0.46 26.41% | 0.61 33.76% | 0.47 24.09% | 0.51 9.68% | |
dividend yield | ||||||||
earnings yield | -0.02 - | -0.04 62.84% | -0.06 66.99% | -0.02 59.88% | -0.03 40.69% | -0.03 10.13% | -0.12 281.55% | |
enterprise value | 864.40M - | 1.06B 22.40% | 932.69M 11.84% | 2.06B 120.36% | 1.41B 31.19% | 1.91B 35.18% | 540.55M 71.73% | |
enterprise value over ebitda | -56.56 - | -32.30 42.88% | -35.32 9.33% | -49.22 39.37% | -29.90 39.24% | -38.49 28.72% | -9.74 74.69% | |
ev to operating cash flow | -34.23 - | -48.77 42.46% | -31.50 35.41% | -48.86 55.10% | -36.32 25.65% | -58.68 61.54% | -16.88 71.23% | |
ev to sales | 60.63 - | 30.62 49.50% | 14.72 51.91% | 27.32 85.58% | 13.94 48.99% | 13.79 1.06% | 3.05 77.87% | |
free cash flow per share | -1.07 - | -0.83 21.86% | -1.31 57.28% | -1.30 0.87% | -1.26 3.08% | -1.05 16.72% | -0.86 17.78% | |
free cash flow yield | -0.03 - | -0.02 21.86% | -0.03 40.92% | -0.02 36.44% | -0.03 43.25% | -0.02 32.86% | -0.07 254.16% | |
graham net net | -4.27 - | -0.80 81.38% | 1.60 301.31% | 2.65 65.56% | 1.46 44.89% | 3.66 150.45% | 2.58 29.68% | |
graham number | 8.62 - | 3.69 57.22% | 13.12 255.93% | 10.59 19.28% | 8.65 18.28% | 12.93 49.39% | 11.22 13.21% | |
income quality | 1.30 - | 0.58 55.81% | 0.56 2.02% | 0.89 57.22% | 0.78 11.99% | 0.59 24.23% | 0.57 3.03% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -4.66 - | -4.91 5.28% | -5.67 15.52% | -9.72 71.44% | -18.85 94.02% | -10.20 45.89% | -8.63 15.44% | |
interest debt per share | 1.31 - | 1.69 29.01% | 2.17 28.34% | 1.63 24.82% | 1.48 9.39% | 2.28 54.15% | 2.17 4.80% | |
inventory turnover | 1.58 - | 1.89 19.88% | 1.54 18.49% | 2.13 38.14% | 1.43 33.12% | 1.96 37.72% | 1.68 14.67% | |
invested capital | -0.28 - | -3.34 1,094.03% | 0.62 118.68% | 0.46 26.41% | 0.61 33.76% | 0.47 24.09% | 0.51 9.68% | |
market cap | 870.14M - | 1.04B 19.38% | 926.99M 10.76% | 2.08B 123.97% | 1.48B 28.92% | 1.89B 28.12% | 476.13M 74.82% | |
net current asset value | -99.59M - | -17.45M 82.48% | 46.98M 369.28% | 101.51M 116.08% | 65.94M 35.04% | 149.09M 126.09% | 126.68M 15.03% | |
net debt to ebitda | 0.38 - | -0.59 256.13% | -0.22 63.22% | 0.50 332.36% | 1.30 159.56% | -0.42 132.62% | -1.16 173.57% | |
net income per share | -0.80 - | -1.31 62.84% | -2.44 86.37% | -1.53 37.43% | -1.45 4.82% | -1.62 11.47% | -1.44 11.42% | |
operating cash flow per share | -1.05 - | -0.76 28.03% | -1.29 70.70% | -1.28 1.06% | -1.12 11.91% | -0.91 18.99% | -0.83 9.41% | |
payables turnover | 3.32 - | 8.69 161.80% | 8.39 3.38% | 8.20 2.34% | 10.70 30.52% | 15.01 40.35% | 8.82 41.26% | |
receivables turnover | 2.73 - | 7.65 179.64% | 7.37 3.66% | 8.29 12.60% | 8.58 3.40% | 7.70 10.23% | 7.51 2.40% | |
research and ddevelopement to revenue | 0.51 - | 0.30 41.56% | 0.19 34.74% | 0.28 45.97% | 0.27 5.52% | 0.26 1.59% | 0.23 11.26% | |
return on tangible assets | -0.45 - | -0.92 104.89% | -0.41 55.66% | -0.28 31.15% | -0.32 14.49% | -0.22 33.13% | -0.21 2.33% | |
revenue per share | 0.59 - | 1.20 103.02% | 2.76 129.29% | 2.28 17.31% | 2.93 28.39% | 3.88 32.27% | 4.56 17.80% | |
roe | 0.20 - | 2.84 1,348.86% | -0.78 127.42% | -0.47 39.91% | -0.64 35.67% | -0.35 44.32% | -0.37 4.17% | |
roic | 0.35 - | -0.47 234.81% | -0.26 45.62% | -0.29 12.42% | -0.37 28.55% | -0.23 39.05% | -0.25 10.99% | |
sales general and administrative to revenue | 1.42 - | 1.01 29.09% | ||||||
shareholders equity per share | -4.10 - | -0.46 88.76% | 3.13 779.77% | 3.26 4.13% | 2.29 29.84% | 4.58 100.22% | 3.90 14.96% | |
stock based compensation to revenue | 0.04 - | 0.03 29.74% | 0.05 78.25% | 0.10 104.42% | 0.14 49.91% | 0.18 25.34% | 0.22 21.65% | |
tangible asset value | -98.58M - | -13.23M 86.58% | 71.89M 643.52% | 107.50M 49.53% | 79.24M 26.29% | 163.88M 106.81% | 151.15M 7.76% | |
tangible book value per share | -4.10 - | -0.46 88.76% | 3.13 779.77% | 3.26 4.13% | 2.29 29.84% | 4.58 100.22% | 3.90 14.96% | |
working capital | 37.42M - | 27.82M 25.64% | 95.56M 243.44% | 153.77M 60.92% | 117.24M 23.76% | 230.41M 96.53% | 210.55M 8.62% |
All numbers in USD (except ratios and percentages)